Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Estimating pre-symptomatic transmission of COVID-19: a secondary analysis using published data
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Estimating pre-symptomatic transmission of COVID-19: a secondary analysis using published data
Creator
Griffin, John
More, Simon
Barber, Ann
Butler, Francis
Byrne, Andrew
Casey, Miriam
Collins, Áine
Hunt, Kevin
Lane, Elizabeth
Madden, Jamie
Mcaloon, Conor
O'brien, Kirsty
Wall, Patrick
Walsh, Kieran
Mc Evoy, David
topic
covid:a77cc03d2656359b108c42c1d03214048b2eb366#this
Source
MedRxiv
abstract
Background: Understanding the extent of virus transmission that can occur before symptom onset is vital for targeting control measures against the global pandemic of COVID-19. Objective: Estimation of (1) the proportion of pre-symptomatic transmission of COVID-19 that can occur and (2) timing of transmission relative to symptom onset. Design: Secondary analysis of published data Data sources: Meta-analysis of COVID-19 incubation period and a rapid systematic review of serial interval and generation time, which are published separately. Methods: Simulations were generated of incubation period and of serial interval or generation time. From these, transmission times relative to symptom onset were calculated and the proportion of pre-symptomatic transmission was estimated. Results: A total of 23 estimates of serial interval and five estimates of generation time from 17 publications were included. These came from nine different data source categories (presented here in descending order of the proportion of pre-symptomatic transmission): Hong Kong, Tianjin, pooled data from Hong Kong and Shenzhen, Singapore, Mainland China excluding Hubei, mixed sources, Shenzhen, northern Italy and Wuhan. Transmission time relative to symptom onset ranged from a mean of 2.05 days before symptom onset for Hong Kong to 1.72 days after symptom onset for Wuhan. Proportion of pre-symptomatic transmission ranged from 33.7% in Wuhan to 72.7% in Hong Kong. Based on individual estimates, transmission time relative to symptom onset ranged from mean of 2.95 days before symptom onset to 1.72 days after symptom onset and proportion of pre-symptomatic transmission ranged from 33.7% to 79.9%. Simple unweighted pooling of estimates based on serial intervals resulted in a mean time of transmission of 0.67 days before symptoms, and an estimated 56.1% of transmission occurring in the pre-symptomatic period. Conclusions: Contact rates between symptomatic infectious and susceptible people are likely to influence the proportion of pre-symptomatic transmission. There is substantial potential for pre-symptomatic transmission of COVID-19 in a range of different contexts. Our work suggests that transmission of SARS-CoV-2 is most likely in the day before symptom onset whereas estimates suggesting most pre-symptomatic transmission highlighted a mean transmission times almost 3 days before symptom onset. These findings highlight the urgent need for extremely rapid and effective case detection, contact tracing and quarantine measures if strict social distancing measures are to be eased.
has issue date
2020-05-11
(
xsd:dateTime
)
bibo:doi
10.1101/2020.05.08.20094870
has license
medrxiv
sha1sum (hex)
a77cc03d2656359b108c42c1d03214048b2eb366
schema:url
https://doi.org/10.1101/2020.05.08.20094870
resource representing a document's title
Estimating pre-symptomatic transmission of COVID-19: a secondary analysis using published data
resource representing a document's body
covid:a77cc03d2656359b108c42c1d03214048b2eb366#body_text
is
http://vocab.deri.ie/void#inDataset
of
proxy:http/ns.inria.fr/covid19/a77cc03d2656359b108c42c1d03214048b2eb366
is
schema:about
of
named entity 'symptom'
named entity 'COVID'
covid:arg/a77cc03d2656359b108c42c1d03214048b2eb366
named entity 'pandemic'
named entity 'pre-symptomatic'
named entity 'pre-symptomatic'
named entity 'Serial interval'
named entity 'serial interval'
named entity 'preprint'
named entity 'health care'
named entity 'coronavirus'
named entity 'asymptomatic'
named entity 'control measures'
named entity 'missing data'
named entity 'serial interval'
named entity 'Italy'
named entity 'serial interval'
named entity 'contact tracing'
named entity 'symptom'
named entity 'China'
named entity 'COVID-19 vaccine'
named entity 'meta-analysis'
named entity 'generation time'
named entity 'preprint'
named entity 'preprint'
named entity 'generation time'
named entity 'serial interval'
named entity 'systematic review'
named entity 'intensive care'
named entity 'systematic review'
named entity 'incubation period'
named entity 'COVID'
named entity 'symptom'
named entity 'incubation period'
named entity 'pre-symptomatic'
named entity '2019-nCoV'
named entity 'CC-BY-ND'
named entity 'generation time'
named entity 'meta-analysis'
named entity 'generation time'
named entity 'preprint'
named entity 'medRxiv'
named entity 'pre-symptomatic'
named entity 'symptom'
named entity 'HIQA'
named entity 'medRxiv'
named entity 'serial interval'
named entity 'asymptomatic'
named entity 'symptom'
named entity 'incubation period'
named entity 'COVID'
named entity 'preprint'
named entity 'generation time'
named entity 'symptom'
named entity 'pre-symptomatic'
named entity 'symptom'
named entity 'April 2020'
named entity 'serial interval'
named entity 'peer review'
named entity '5.1'
named entity 'contact tracing'
named entity 'incubation period'
named entity 'symptom'
named entity 'Disease Control and Prevention'
named entity 'preprint'
named entity 'symptom'
named entity 'incubation period'
named entity 'contact tracing'
named entity 'serial interval'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 5
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software